Lower Risk of Death and Kidney Failure Associated with Higher Target (vs. Below-Target) Doses of RAS Inhibitors in Octogenarians with HFrEF

Sin MK, Allman RM, Faselis C, Aronow WS, Brown CJ, Lam PH, Wu WC, Zeng-Treitler Q, Patel SS, Raman VK, Zhang S, Sheriff HM, Morgan CJ, Heidenreich PA, Fonarow GC, Ahmed A. Lower Risk of Death and Kidney Failure Associated with Higher Target (vs. Below-Target) Doses of RAS Inhibitors in Octogenarians with HFrEF. Am J Med. 2024 Nov 12:S0002-9343(24)00710-1. doi: 10.1016/j.amjmed.2024.10.019. Epub ahead of print. PMID: 39551174.


Related Posts